Cargando…

Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework

In the present work, the porous metal-organic framework (MOF) Basolite(®)F300 (Fe-BTC) was tested as a potential drug-releasing depot to enhance the solubility of the anticancer drug paclitaxel (PTX) and to prepare controlled release formulations after its encapsulation in amphiphilic methoxy poly(e...

Descripción completa

Detalles Bibliográficos
Autores principales: Bikiaris, Nikolaos D., Ainali, Nina Maria, Christodoulou, Evi, Kostoglou, Margaritis, Kehagias, Thomas, Papasouli, Emilia, Koukaras, Emmanuel N., Nanaki, Stavroula G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763675/
https://www.ncbi.nlm.nih.gov/pubmed/33322372
http://dx.doi.org/10.3390/nano10122490
_version_ 1783628074681630720
author Bikiaris, Nikolaos D.
Ainali, Nina Maria
Christodoulou, Evi
Kostoglou, Margaritis
Kehagias, Thomas
Papasouli, Emilia
Koukaras, Emmanuel N.
Nanaki, Stavroula G.
author_facet Bikiaris, Nikolaos D.
Ainali, Nina Maria
Christodoulou, Evi
Kostoglou, Margaritis
Kehagias, Thomas
Papasouli, Emilia
Koukaras, Emmanuel N.
Nanaki, Stavroula G.
author_sort Bikiaris, Nikolaos D.
collection PubMed
description In the present work, the porous metal-organic framework (MOF) Basolite(®)F300 (Fe-BTC) was tested as a potential drug-releasing depot to enhance the solubility of the anticancer drug paclitaxel (PTX) and to prepare controlled release formulations after its encapsulation in amphiphilic methoxy poly(ethylene glycol)-poly(ε-caprolactone) (mPEG-PCL) nanoparticles. Investigation revealed that drug adsorption in Fe-BTC reached approximately 40%, a relatively high level, and also led to an overall drug amorphization as confirmed by differential scanning calorimetry (DSC) and X-ray diffraction (XRD). The dissolution rate of PTX-loaded MOF was substantially enhanced achieving a complete (100%) release within four days, while the neat drug only reached a 13% maximum rate (3–4 days). This PTX-Fe-BTC nanocomposite was further encapsulated into a mPEG-PCL matrix, a typical aliphatic amphiphilic copolyester synthesized in our lab, whose biocompatibility was validated by in vitro cytotoxicity tests toward human umbilical vein endothelial cells (HUVEC). Encapsulation was performed according to the solid-in-oil-in-water emulsion/solvent evaporation technique, resulting in nanoparticles of about 143 nm, slightly larger of those prepared without the pre-adsorption of PTX on Fe-BTC (138 nm, respectively). Transmission electron microscopy (TEM) imaging revealed that spherical nanoparticles with embedded PTX-loaded Fe-BTC nanoparticles were indeed fabricated, with sizes ranging from 80 to 150 nm. Regions of the composite Fe-BTC-PTX system in the infrared (IR) spectrum are identified as signatures of the drug-MOF interaction. The dissolution profiles of all nanoparticles showed an initial burst release, attributed to the drug amount located at the nanoparticles surface or close to it, followed by a steadily and controlled release. This is corroborated by computational analysis that reveals that PTX attaches effectively to Fe-BTC building blocks, but its relatively large size limits diffusion through crystalline regions of Fe-BTC. The dissolution behaviour can be described through a bimodal diffusivity model. The nanoparticles studied could serve as potential chemotherapeutic candidates for PTX delivery.
format Online
Article
Text
id pubmed-7763675
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77636752020-12-27 Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework Bikiaris, Nikolaos D. Ainali, Nina Maria Christodoulou, Evi Kostoglou, Margaritis Kehagias, Thomas Papasouli, Emilia Koukaras, Emmanuel N. Nanaki, Stavroula G. Nanomaterials (Basel) Article In the present work, the porous metal-organic framework (MOF) Basolite(®)F300 (Fe-BTC) was tested as a potential drug-releasing depot to enhance the solubility of the anticancer drug paclitaxel (PTX) and to prepare controlled release formulations after its encapsulation in amphiphilic methoxy poly(ethylene glycol)-poly(ε-caprolactone) (mPEG-PCL) nanoparticles. Investigation revealed that drug adsorption in Fe-BTC reached approximately 40%, a relatively high level, and also led to an overall drug amorphization as confirmed by differential scanning calorimetry (DSC) and X-ray diffraction (XRD). The dissolution rate of PTX-loaded MOF was substantially enhanced achieving a complete (100%) release within four days, while the neat drug only reached a 13% maximum rate (3–4 days). This PTX-Fe-BTC nanocomposite was further encapsulated into a mPEG-PCL matrix, a typical aliphatic amphiphilic copolyester synthesized in our lab, whose biocompatibility was validated by in vitro cytotoxicity tests toward human umbilical vein endothelial cells (HUVEC). Encapsulation was performed according to the solid-in-oil-in-water emulsion/solvent evaporation technique, resulting in nanoparticles of about 143 nm, slightly larger of those prepared without the pre-adsorption of PTX on Fe-BTC (138 nm, respectively). Transmission electron microscopy (TEM) imaging revealed that spherical nanoparticles with embedded PTX-loaded Fe-BTC nanoparticles were indeed fabricated, with sizes ranging from 80 to 150 nm. Regions of the composite Fe-BTC-PTX system in the infrared (IR) spectrum are identified as signatures of the drug-MOF interaction. The dissolution profiles of all nanoparticles showed an initial burst release, attributed to the drug amount located at the nanoparticles surface or close to it, followed by a steadily and controlled release. This is corroborated by computational analysis that reveals that PTX attaches effectively to Fe-BTC building blocks, but its relatively large size limits diffusion through crystalline regions of Fe-BTC. The dissolution behaviour can be described through a bimodal diffusivity model. The nanoparticles studied could serve as potential chemotherapeutic candidates for PTX delivery. MDPI 2020-12-11 /pmc/articles/PMC7763675/ /pubmed/33322372 http://dx.doi.org/10.3390/nano10122490 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bikiaris, Nikolaos D.
Ainali, Nina Maria
Christodoulou, Evi
Kostoglou, Margaritis
Kehagias, Thomas
Papasouli, Emilia
Koukaras, Emmanuel N.
Nanaki, Stavroula G.
Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework
title Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework
title_full Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework
title_fullStr Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework
title_full_unstemmed Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework
title_short Dissolution Enhancement and Controlled Release of Paclitaxel Drug via a Hybrid Nanocarrier Based on mPEG-PCL Amphiphilic Copolymer and Fe-BTC Porous Metal-Organic Framework
title_sort dissolution enhancement and controlled release of paclitaxel drug via a hybrid nanocarrier based on mpeg-pcl amphiphilic copolymer and fe-btc porous metal-organic framework
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763675/
https://www.ncbi.nlm.nih.gov/pubmed/33322372
http://dx.doi.org/10.3390/nano10122490
work_keys_str_mv AT bikiarisnikolaosd dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework
AT ainalininamaria dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework
AT christodoulouevi dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework
AT kostogloumargaritis dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework
AT kehagiasthomas dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework
AT papasouliemilia dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework
AT koukarasemmanueln dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework
AT nanakistavroulag dissolutionenhancementandcontrolledreleaseofpaclitaxeldrugviaahybridnanocarrierbasedonmpegpclamphiphiliccopolymerandfebtcporousmetalorganicframework